Crossref
Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells
Carcinogenesis · 30.10.2026
DOI: 10.1093/carcin/bgag072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, online erschienen am 30.10.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis. https://doi.org/10.1093/carcin/bgag072
Vancouver
Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis. 2026. doi:10.1093/carcin/bgag072
BibTeX
@article{euvimed2026,
title = {Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells},
journal = {Carcinogenesis},
year = {2026},
doi = {10.1093/carcin/bgag072}
}
EUVIMED